Events

Outcomes of DOGE Impacts on the Early-Career Workforce and Funder Opportunities for Action [December 15, 2026]

12/15/26, 2-3pm ET - Webinars

Join us for a discussion of survey findings presented by Dr. Alycia Halliday and Dr. Hannah Rea of the Autism Science Foundation on how DOGE-related changes are affecting early-career researchers. This webinar follows up on the survey the Autism Science Foundation circulated through HRA last fall, bringing the conversation full circle with the survey findings and next steps. We will explore key results, implications for the research community, priorities for funders and advocacy organizations, and opportunities for collective action and further analysis.

Speakers

Hannah Rea, PhD – Scientific Program Officer, Autism Science Foundation
Hannah Rea, PhD, is the Scientific Program Officer at ASF, where she manages scientific activities, grants, and initiatives. She earned her PhD in clinical psychology from the University of Georgia, completed a predoctoral internship at the University of California MIND Institute, and completed a postdoctoral fellowship at the University of Washington. She also holds a faculty appointment at West Virginia University. Her research and clinical work focus on challenging behaviors and executive functioning in autism and rare genetic disorders associated with autism.

Alycia Halladay, PhD – Chief Science Officer, Autism Science Foundation
Alycia oversees the scientific activities, grants, and initiatives of ASF. She also produces a weekly podcast aimed specifically at explaining scientific information to the public. Prior to joining ASF in 2014, she served as the Senior Director of Clinical and Environmental Sciences at Autism Speaks. She has authored over two dozen peer reviewed papers in science journals. Alycia also serves on the Board of Directors for the Phelan McDermid Syndrome Foundation and on the Interagency Autism Coordinating Committee. She received a Ph.D. in biopsychology from Rutgers in 2001 and completed a postdoctoral fellowship in pharmacology and toxicology at the University of Medicine and Dentistry of NJ in 2004 and is on the editorial board of Neurotoxicology and Frontiers in Pediatrics. She still holds a faculty appointment at Rutgers. She also has twin daughters, one of whom has ASD.